JP2019531742A5 - - Google Patents

Download PDF

Info

Publication number
JP2019531742A5
JP2019531742A5 JP2019520685A JP2019520685A JP2019531742A5 JP 2019531742 A5 JP2019531742 A5 JP 2019531742A5 JP 2019520685 A JP2019520685 A JP 2019520685A JP 2019520685 A JP2019520685 A JP 2019520685A JP 2019531742 A5 JP2019531742 A5 JP 2019531742A5
Authority
JP
Japan
Prior art keywords
receptor
antigen
protein
tcr
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019520685A
Other languages
English (en)
Japanese (ja)
Other versions
JP7236380B2 (ja
JP2019531742A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/076800 external-priority patent/WO2018073393A2/en
Publication of JP2019531742A publication Critical patent/JP2019531742A/ja
Publication of JP2019531742A5 publication Critical patent/JP2019531742A5/ja
Application granted granted Critical
Publication of JP7236380B2 publication Critical patent/JP7236380B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019520685A 2016-10-19 2017-10-19 治療に適したｔａｌエフェクターヌクレアーゼ（ｔａｌｅｎ）改変同種異系細胞 Active JP7236380B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662410187P 2016-10-19 2016-10-19
US62/410,187 2016-10-19
DKPA201770240 2017-03-31
DKPA201770240 2017-03-31
PCT/EP2017/076800 WO2018073393A2 (en) 2016-10-19 2017-10-19 Tal-effector nuclease (talen) -modified allogenic cells suitable for therapy

Publications (3)

Publication Number Publication Date
JP2019531742A JP2019531742A (ja) 2019-11-07
JP2019531742A5 true JP2019531742A5 (https=) 2023-01-25
JP7236380B2 JP7236380B2 (ja) 2023-03-09

Family

ID=60268352

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019520685A Active JP7236380B2 (ja) 2016-10-19 2017-10-19 治療に適したｔａｌエフェクターヌクレアーゼ（ｔａｌｅｎ）改変同種異系細胞

Country Status (5)

Country Link
US (1) US20230138915A1 (https=)
EP (1) EP3529265A2 (https=)
JP (1) JP7236380B2 (https=)
AU (1) AU2017347685B2 (https=)
CA (1) CA3041039A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020095249A1 (en) 2018-11-07 2020-05-14 Crispr Therapeutics Ag Anti-liv1 immune cell cancer therapy
JP2023529211A (ja) * 2020-06-11 2023-07-07 ノバルティス アーゲー Ｚｂｔｂ３２阻害剤及びその使用
CN117129690B (zh) * 2023-09-26 2025-06-06 杭州师范大学 Grhl1在her2-乳腺癌诊断及预后评估中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014029417B1 (pt) * 2012-05-25 2023-03-07 Cellectis Método ex vivo para a preparação de células t para imunoterapia
WO2014191128A1 (en) * 2013-05-29 2014-12-04 Cellectis Methods for engineering t cells for immunotherapy by using rna-guided cas nuclease system
JP6681837B2 (ja) * 2014-03-11 2020-04-15 セレクティスＣｅｌｌｅｃｔｉｓ 同種移植に適合するｔ細胞を作製するための方法
WO2016124765A1 (en) * 2015-02-06 2016-08-11 Cellectis Primary hematopoietic cells genetically engineered by slow release of nucleic acids using nanoparticles
AU2016243583B2 (en) * 2015-03-27 2022-03-10 President And Fellows Of Harvard College Modified T cells and methods of making and using the same
JP6816133B2 (ja) * 2015-10-05 2021-01-20 プレシジョン バイオサイエンシズ，インク． 改変ヒトｔ細胞受容体アルファ定常領域遺伝子を含む遺伝子改変細胞
MX2018012472A (es) * 2016-04-15 2019-08-12 Alpine Immune Sciences Inc Proteinas inmunomoduladoras variantes de ligando icos y sus usos.

Similar Documents

Publication Publication Date Title
IL273201B1 (en) Novel platforms for co-stimulation, novel car designs and other enhancements for adoptive cellular therapy
JP2023518049A5 (https=)
US12410248B2 (en) Chimeric antigen receptor and its use
JP2025037871A5 (https=)
IL321733A (en) Compositions and methods for selective degradation of proteins
JP2024518011A5 (https=)
JP2021500861A5 (https=)
HRP20202062T1 (hr) Puferi za stabilizaciju lentivirusnih pripravaka
JP2020517263A5 (https=)
IL297547A (en) Therapeutic interventional particles for the corona virus
FI3380620T3 (fi) Optimoituja lentiviruksen siirtovektoreita ja niiden käyttötapoja
AU2017233072B2 (en) Multimodal vector for dendritic cell infection
IL297514A (en) Vectors and methods for in vivo transduction
JP2024510900A5 (https=)
KR20230150834A (ko) Ap-1 전사 인자를 인코딩하는 코돈-최적화된 뉴클레오티드 서열
CN110511912A (zh) 免疫细胞的功能调节
JP2019531742A5 (https=)
Zhou et al. A novel transgenic mouse model for immunological evaluation of carcinoembryonic antigen–based DNA minigene vaccines
JP2022516710A5 (https=)
JP7236380B2 (ja) 治療に適したｔａｌエフェクターヌクレアーゼ（ｔａｌｅｎ）改変同種異系細胞
EP4486373A1 (en) Allogeneic therapeutic cells
Zhu et al. HLA-A0201 positive pancreatic cell lines: new findings and discrepancies
HK40115321A (zh) 同种异体治疗性细胞
WO2026069206A1 (en) Hypoimmunogenic modified gamma delta t cells
EA050762B1 (ru) Аллогенные терапевтические клетки